Hatchtech to Go to Phase II Trial Published: Jan 21, 2008 Biotechnology company Hatchtech says its new head lice treatment product will progress to phase two trials after it received the green light from the US Food and Drug Administration (FDA). Related links Sydney Morning Herald This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news